Beyond Blood Culture and Gram Stain Analysis: A Review of Molecular Techniques for the Early Detection of Bacteremia in Surgical Patients

Surgical Infections

Volumn 17, Issue 3, 2016, Pages 294-302

  Scerbo, Michelle H ^a   Kaplan, Heidi B ^a   Dua, Anahita ^c   Litwin, Douglas B ^a   Ambrose, Catherine G ^b   Moore, Laura J ^a   Murray, Col Clinton K ^d   Wade, Charles E ^a   Holcomb, John B ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d BROOKE ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CRYSTAL VIOLET; GRAM'S STAIN; PHENAZINE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTEREMIA; BACTERIUM DETECTION; BLOOD CULTURE; BLOOD SAMPLING; BLOODSTREAM INFECTION; ELECTROSPRAY MASS SPECTROMETRY; FLUORESCENCE MICROSCOPY; GRAM STAINING; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; META ANALYSIS; MICROORGANISM DETECTION; PATIENT SELECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; SURGICAL INFECTION; SURGICAL PATIENT; SYSTEMATIC REVIEW; MICROBIOLOGY; MOLECULAR TYPING; POSTOPERATIVE COMPLICATIONS; PROCEDURES; STAINING;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BLOOD CULTURE; GENTIAN VIOLET; HUMANS; MOLECULAR TYPING; PHENAZINES; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATIONS; STAINING AND LABELING;

EID: 84971324138     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2015.099     Document Type: Review

References (85)

1. Levy MM, Dellinger RP, Townsend SR, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med 2010;38:367-374.
2. Hall MJ, Williams SN, DeFrances CJ, Golosinskiy A. Inpatient care for septicemia or sepsis: A challenge for patients and hospitals. NCHS Data Brief 2011;62:1-8.
3. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-1310.
4. Mayr VD, Dunser MW, Greil V, et al. Causes of death and determinants of outcome in critically ill patients. Crit Care 2006;10:R154.
5. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003. Crit Care Med 2007;35:1244-1250.
6. Moore LJ, Moore FA, Todd SR, et al. Sepsis in general surgery: the 2005-2007 national surgical quality improvement program perspective. Arch Surg 2010;145:695-700.
7. Leligdowicz A, Dodek PM, Norena M, et al. Association between source of infection and hospital mortality in patients who have septic shock. Am J Respir Crit Care Med 2014;189:1204-1213.
8. Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: A prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997;24:584-602.
9. Pittet D, Li N, Woolson RF, Wenzel RP. Microbiological factors influencing the outcome of nosocomial bloodstream infections: A 6-year validated, population-based model. Clin Infect Dis 1997;24:1068-1078.
10. Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med 2006;34:344-353.
11. Lagu T, Rothberg MB, Shieh MS, et al. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Cri Care Med 2012;40:754-761.
12. Moore LJ, Jones SL, Kreiner LA, et al. Validation of a screening tool for the early identification of sepsis. J Trauma 2009;66:1539-1546.
13. 42nd Critical Care Congress Review. Society of Critical Care Medicine. www.sccm.org. (Last accessed July 1, 2014.)
14. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013; 39:165-228.
15. Levy MM, Rhodes A, Phillips GS, et al. Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. Crit Care Med 2015;43: 3-12.
16. Bellomo R, Bersten AD, Boots RJ, et al. The use of antimicrobials in ten Australian and New Zealand intensive care units. The Australian and New Zealand Intensive Care Multicentre Studies Group Investigators. Anaesth Intensive Care 1998;26:648-653.
17. Peters RP, van Agtmael MA, Danner SA, et al. New developments in the diagnosis of bloodstream infections. Lancet Infect Dis 2004;4:751-760.
18. Tsalik EL, Jones D, Nicholson B, et al. Multiplex PCR to diagnose bloodstream infections in patients admitted from the emergency department with sepsis. J Clin Microbiol 2010;48:26-33.
19. Coburn B, Morris AM, Tomlinson G, Detsky AS. Does this adult patient with suspected bacteremia require blood cultures? JAMA 2012;308:502-511.
20. Ahmad S, Khan Z, Mustafa AS, Khan ZU. Seminested PCR for diagnosis of candidemia: Comparison with culture, antigen detection, and biochemical methods for species identification. J Clin Microbiol 2002;40:2483-2489.
21. Dierkes C, Ehrenstein B, Siebig S, et al. Clinical impact of a commercially available multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis. BMC Infect Dis 2009;9:126.
22. Lodes U, Bohmeier B, Lippert H, et al. PCR-based rapid sepsis diagnosis effectively guides clinical treatment in patients with new onset of SIRS. Langenbecks Arch Surg 2012;397:447-455.
23. Vijayakumar R, Giri S, Kindo AJ. Molecular species identification of Candida from blood samples of intensive care unit patients by polymerase chain reaction-restricted fragment length polymorphism. J Lab Physicians 2012; 4:1-4.
24. Wallet F, Loiez C, Herwegh S, Courcol RJ. Usefulness of real-time PCR for the diagnosis of sepsis in ICU-acquired infections. Infect Disord Drug Targets 2011;11:348-353.
25. Afshari A, Schrenzel J, Ieven M, Harbarth S. Bench-tobedside review: Rapid molecular diagnostics for bloodstream infection-A new frontier? Crit Care 2012;16:222.
26. Ferrer R, Martin-Loeches I, Phillips G, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: Results from a guidelinebased performance improvement program. Crit Care Med 2014;42:1749-1755.
27. Ibrahim EH, Sherman G, Ward S, et al. The influence of inadequate antimicrobial treatment of bloodstreaminfections on patient outcomes in the ICUsetting.Chest 2000;118:146-155.
28. Zaragoza R, Artero A, Camarena JJ, et al. The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. Clin Microbiol Infect 2003;9:412-418.
29. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients. Chest 1999;115:462-474.
30. Vogelaers D, De Bels D, Foret F, et al. Patterns of antimicrobial therapy in severe nosocomial infections: Empiric choices, proportion of appropriate therapy, and adaptation rates-A multicentre, observational survey in critically ill patients. Int J Antimicrob Agents 2010;35:375-381.
31. Havey TC, Fowler RA, Pinto R, et al. Duration of antibiotic therapy for critically ill patients with bloodstream infections: A retrospective cohort study. Can J Infect Dis Med Microbiol 2013;24:129-137.
32. U.S. Department of Health and Human Services. Antibiotic/ Antimicrobial Resistance. Center for Disease Control and Prevention Threat Report 2013.www.cdc.gov/drugresistance/ threat-report-2013/. (Last accessed February 5, 2014.)
33. Bassetti M, Merelli M, Temperoni C, Astilean A. New antibiotics for bad bugs: Where are we? Ann Clin Microbiol Antimicrob 2013;12:22.
34. Hranjec T, Rosenberger LH, Swenson B, et al. Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unitacquired infection: A quasi-experimental, before and after observational cohort study. Lancet Infect Dis 2012;12:774-780.
35. Lodes U, Meyer F, Konig B, Lippert H. [Microbiological sepsis screening in surgical ICU patients with the ''light-Cycler'' Septifast test-A pilot study]. Zentralbl Chir 2009; 134:249-253.
36. Waites KB, Canupp KC. Evaluation of BacT/ALERT system for detection of Mycoplasma hominis in simulated blood cultures. J Clin Microbiol 2001;39:4328-4331.
37. Rihs JD, Yu VL, Zuravleff JJ, et al. Isolation of Legionella pneumophila from blood with the BACTEC system: a prospective study yielding positive results. J Clin Microbiol 1985;22:422-424.
38. Christner M, Rohde H, Wolters M, et al. Rapid identification of bacteria from positive blood culture bottles by use of matrix-assisted laser desorption-ionization time of flight mass spectrometry fingerprinting. J Clin Microbiol 2010;48: 1584-1591.
39. Tan TY, Ng LS, Kwang LL. Evaluation of disc susceptibility tests performed directly from positive blood cultures. J Clin Pathol 2008;61:343-346.
40. Jorgensen JH, Mirrett S, McDonald LC, et al. Controlled clinical laboratory comparison of BACTEC plus aerobic/F resin medium with BacT/Alert aerobicFANmediumfor detection of bacteremia and fungemia. J Clin Microbiol 1997;35:53-58.
41. Ziegler R, Johnscher I, Martus P, et al. Controlled clinical laboratory comparison of two supplemented aerobic and anaerobic media used in automated blood culture systems to detect bloodstream infections. J Clin Microbiol 1998;36:657-661.
42. Miller NS, Rogan D, Orr BL, Whitney D. Comparison of BD Bactec Plus blood culture media to VersaTREK Redox blood culture media for detection of bacterial pathogens in simulated adult blood cultures containing therapeutic concentrations of antibiotics. J Clin Microbiol 2011;49:1624-1627.
43. Yagupsky P, Nolte FS. Quantitative aspects of septicemia. Clin Microbiol Rev 1990;3:269-279.
44. Willmann M, Kuebart I, Vogel W, et al. Time to positivity as prognostic tool in patients with Pseudomonas aeruginosa bloodstream infection. J Infect 2013;67:416-423.
45. Palmer HR, Palavecino EL, Johnson JW, et al. Clinical and microbiological implications of time-to-positivity of blood cultures in patients with Gram-negative bacilli bacteremia. Eur J Microbiol Infect Dis 2013;32:955-959.
46. van Heijenoort J. Formation of the glycan chains in the synthesis of bacterial peptidoglycan. Glycobiology 2001; 11:25r-36r.
47. Kumar A, Ellis P, Arabi Y, et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 2009;136:1237-1248.
48. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589-1596.
49. Fenollar F, Raoult D. Molecular diagnosis of bloodstream infections caused by non-cultivable bacteria. Int J Antimicrob Agents 2007;30:S7-S15.
50. Fields BS, Benson RF, Besser RE. Legionella and Legionnaires' disease: 25 years of investigation. Clin Microbiol Rev 2002;15:506-526.
51. Hall KK, Lyman JA. Updated review of blood culture contamination. Clin Microbiol Rev 2006;19:788-802.
52. Wieser A, Schneider L, Jung J, Schubert S. MALDI-TOF MS in microbiological diagnostics-identification of microorganisms and beyond (mini review). Appl Microbiol Biotechnol 2012;93:965-974.
53. Tan KE, Ellis BC, Lee R, et al. Prospective evaluation of a matrix-assisted laser desorption ionization-time of flight mass spectrometry system in a hospital clinical microbiology laboratory for identification of bacteria and yeasts: a bench-by-bench study for assessing the impact on time to identification and cost-effectiveness. J Clin Microbiol 2012; 50:3301-3308.
54. Marvin LF, Roberts MA, Fay LB. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in clinical chemistry. Clinica Chim Acta 2003;337:11-21.
55. Kok J, Thomas LC, Olma T, et al. Identification of bacteria in blood culture broths using matrix-assisted laser desorption-ionization Sepsityper and time of flight mass spectrometry. PloS One 2011;6:e23285.
56. Harris DM, Hata DJ. Rapid identification of bacteria and Candida using PNA-FISH from blood and peritoneal fluid cultures: a retrospective clinical study. Ann Clin Microbiol Antimicrob 2013;12:2.
57. Forrest GN. PNA FISH: present and future impact on patient management. Expert Rev Mol Diagn 2007;7:231-236.
58. Pace S, Steigelman D, Norton SA, Krivda S. Field-based PCR for rapid diagnosis of cutaneous anthrax in the deployed setting using the joint biological agent identification and diagnostic system. Mil Med 2013;178:e944-e947.
59. Louie RF, Tang Z, Albertson TE, et al. Multiplex polymerase chain reaction detection enhancement of bacteremia and fungemia. Crit Care Med 2008;36:1487-1492.
60. Broccolo F. A multiplex real-time PCR-platform integrated into automated extraction method for the rapid detection and measurement of oncogenic HPV type-specific viral DNA load from cervical samples. Methods Mol Biol 2014;1160:87-97.
61. Fernandez AL, Varela E, Martinez L, et al. Evaluation of a multiplex real-time PCR assay for detecting pathogens in cardiac valve tissue in patients with endocarditis. Rev Esp Cardiol 2010;63:1205-1208.
62. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008;3:1101-1108.
63. Nijhuis RH, van Maarseveen NM, van Hannen EJ, et al. A rapid and high-throughput screening approach for methicillinresistant Staphylococcus aureus based on the combination of two different real-time PCR assays. J Clin Microbiol 2014; 52:2861-2867.
64. Hamilton LR, George DL, Scoville SL, et al. PCR for rapid diagnosis of acute Q fever at a combat support hospital in Iraq. Mil Med 2011;176:103-105.
65. Jaziri F, Parisot N, Abid A, et al. PhylOPDb: a 16S rRNA oligonucleotide probe database for prokaryotic identification. Database 2014;2014:bau036.
66. Matero P, Hemmila H, Tomaso H, PiiparinenH, Rantakokko-Jalava K, Nuotio L, et al. Rapid field detection assays for Bacillus anthracis, Brucella spp., Francisella tularensis and Yersinia pestis. Clin Microbiol Infect 2011;17:34-43.
67. Janse I, Hamidjaja RA, Bok JM, van Rotterdam BJ. Reliable detection of Bacillus anthracis, Francisella tularensis and Yersinia pestis by using multiplex qPCR including internal controls for nucleic acid extraction and amplification. BMC Microbiol 2010;10:314.
68. Avolio M, Diamante P, Modolo ML, et al. Direct molecular detection of pathogens in blood as specific rule-in diagnostic biomarker in patients with presumed sepsis: our experience on a heterogeneous cohort of patients with signs of infective systemic inflammatory response syndrome. Shock 2014;42:86-92.
69. Chang SS, HsiehWH, Liu TS, et al.Multiplex PCR system for rapid detection of pathogens in patientswith presumed sepsis-a systemic reviewand meta-analysis. PloS One 2013;8:e62323.
70. Zucol F, Ammann RA, Berger C, et al. Real-time quantitative broad-range PCR assay for detection of the 16S rRNA gene followed by sequencing for species identification. J Clin Microbiol 2006;44:2750-2759.
71. Ambrose CG MJ, Gogola GR, Gomez K, Kaplan HB. Persistence of Bacterial DNA in Orthopaedic Infections. [In press 2012.]
72. Wellinghausen N, Kochem AJ, Disque C, et al. Diagnosis of bacteremia in whole-blood samples by use of a commercial universal 16S rRNA gene-based PCR and sequence analysis. J Clin Microbiol 2009;47:2759-2765.
73. Post JC, Aul JJ, White GJ, et al. PCR-based detection of bacterial DNA after antimicrobial treatment is indicative of persistent, viable bacteria in the chinchilla model of otitis media. A J Otolaryngol 1996;17:106-111.
74. Tafelski S, Nachtigall I, Adam T, et al. Randomized controlled clinical trial evaluating multiplex polymerase chain reaction for pathogen identification and therapy adaptation in critical care patients with pulmonary or abdominal sepsis. J Int Med Res 2015;43:364-377.
75. Schreiber J, Nierhaus A, Braune SA, et al. Comparison of three different commercial PCR assays for the detection of pathogens in critically ill sepsis patients. Med Klin Intensivmed Notfmed 2013;108:311-318.
76. Haag H, Locher F, Nolte O.Molecular diagnosis of microbial aetiologies using SepsiTest in the daily routine of a diagnostic laboratory. Diagn Microbiol Infect Dis 2013;76:413-418.
77. National Taiwan University Hospital; Taiwan: Department of Health. Establish Quantitative PCR toMeasure Bacteria Load of the VRE Bacteremia. In: ClinicalTrials.gov [Internet]. Bethesda (MD):National Library ofMedicine (US). 2000-[cited 2015 Sept 30]. Available from: https://clinicaltrials.gov/ct2/ show/NCT01265095 NLM Identifier: NCT01265095.
78. VA Medical Center, Houston; Baylor College of Medicine, Cepheid. Rapid Test to Detect Staphylococcus Aureus in Blood andWound Infections. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000-[cited 2015 Sept 30]. Available from: https://clinicaltrials.gov/ ct2/show/NCT01198262 NLM Identifier: NCT01198262.
79. Bonten, Marc; UMC Utrecht. Clinical Trial to Reduce Antibiotic Resistance in European Intensive Cares (MOSAR-ICU). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library ofMedicine (US). 2000-[cited 2015 Sept 30]. Available from: https://clinicaltrials.gov/ct2/show/NCT00976638 NLM Identifier: NCT00976638.
80. Fahy, Brenda; University of Florida. A New Method for Detection of Bacteria in the Bloodstream. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000-[cited 2015 Sept 30]. Available from: https:// clinicaltrials.gov/ct2/show/NCT02323165 NLM Identifier: NCT02323165.
81. Leibovici, Leonard; Rabin Medical Center. Optimal Antibiotic Treatment of Moderate to Severe Bacterial Infections (CDSS). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000-[cited 2015 Sept 30]. Available from: https://clinicaltrials.gov/ct2/show/ NCT01338116 NLM Identifier: NCT01338116.
82. University Hospital Muenster; Pfizer, Hoffmann-La Roche. Value of the LightCycler- SeptiFast Test MGRADE for the Pathogen Detection in Neutropenic Hematological Patients. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000-[cited 2015 Sept 30]. Available from: https://clinicaltrials.gov/ct2/show/NCT01114165 NLM Identifier: NCT01114165.
83. TIMSIT, Jean-Francois; University Hospital, Grenoble. Benefit of SeptiFast Multiplex PCR in the Etiologic Diagnosis and Therapeutic Approach for Onco-hematology Patients Presenting Sepsis (SEPTIFAST). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000-[cited 2015 Sept 30]. Available from: https://clinicaltrials.gov/ ct2/show/NCT00561639 NLM Identifier: NCT00561639.
84. Assistance Publique-Hopitaux de Paris; Hoffmann-La Roche. Diagnosis of Septicaemia by Detection of Microbial DNA in Blood in Severe Infections (EVAMICA). In: ClinicalTrials. gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000-[cited 2015 Sept 30]. Available from: https://clinicaltrials.gov/ct2/show/NCT00709358 NLM Identifier: NCT00709358.
85. Pasqualini L, Mencacci A, Leli C, et al. Diagnostic performance of a multiple real-time PCR assay in patients with suspected sepsis hospitalized in an internal medicine ward. J Clin Microbiol 2012;50:1285-1288.